FDA D.I.S.C.O. Burst Edition: FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia
0:00
2:30
Listen to a soundcast of the October 1, 2021 FDA approval of Tecartus (brexucabtagene autoleucel) for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
Weitere Episoden von „FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)“
Verpasse keine Episode von “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” und abonniere ihn in der kostenlosen GetPodcast App.